nodes	percent_of_prediction	percent_of_DWPC	metapath
Choline—osteoarthritis—Prednisone—psoriasis	0.908	1	CpDpCtD
Choline—PLD1—Immune System—ICAM1—psoriasis	6.19e-05	0.000675	CbGpPWpGaD
Choline—PLD1—Immune System—NFKBIA—psoriasis	6.14e-05	0.00067	CbGpPWpGaD
Choline—SLC44A3—Metabolism—PPARG—psoriasis	6.11e-05	0.000666	CbGpPWpGaD
Choline—SLC44A4—Metabolism—PPARG—psoriasis	6.11e-05	0.000666	CbGpPWpGaD
Choline—SLC44A2—Metabolism—PPARG—psoriasis	6.11e-05	0.000666	CbGpPWpGaD
Choline—SLC44A1—Metabolism—PPARG—psoriasis	6.11e-05	0.000666	CbGpPWpGaD
Choline—CHAT—Metabolism—CAT—psoriasis	6.1e-05	0.000665	CbGpPWpGaD
Choline—PLD2—Immune System—ICAM1—psoriasis	5.96e-05	0.00065	CbGpPWpGaD
Choline—SLC22A2—Metabolism—NDUFA5—psoriasis	5.93e-05	0.000647	CbGpPWpGaD
Choline—PLD2—Immune System—NFKBIA—psoriasis	5.91e-05	0.000645	CbGpPWpGaD
Choline—ADORA2A—Circadian rythm related genes—JUN—psoriasis	5.9e-05	0.000643	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—CCL20—psoriasis	5.8e-05	0.000632	CbGpPWpGaD
Choline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	5.77e-05	0.000629	CbGpPWpGaD
Choline—PDE3A—Hemostasis—NOS2—psoriasis	5.72e-05	0.000624	CbGpPWpGaD
Choline—BCHE—Metabolism—CYP2S1—psoriasis	5.65e-05	0.000616	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—CCL20—psoriasis	5.62e-05	0.000613	CbGpPWpGaD
Choline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	5.62e-05	0.000612	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—CCL20—psoriasis	5.53e-05	0.000603	CbGpPWpGaD
Choline—SLC22A1—Metabolism—NDUFA5—psoriasis	5.53e-05	0.000603	CbGpPWpGaD
Choline—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	5.51e-05	0.000601	CbGpPWpGaD
Choline—ADORA2A—Signaling by NGF—TYK2—psoriasis	5.5e-05	0.000599	CbGpPWpGaD
Choline—PCYT1A—Metabolism—PPARG—psoriasis	5.45e-05	0.000594	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—CCL20—psoriasis	5.26e-05	0.000574	CbGpPWpGaD
Choline—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.26e-05	0.000574	CbGpPWpGaD
Choline—ADORA2B—GPCR ligand binding—CXCL8—psoriasis	5.16e-05	0.000563	CbGpPWpGaD
Choline—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	5.14e-05	0.00056	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—CCL20—psoriasis	5.12e-05	0.000559	CbGpPWpGaD
Choline—PLD1—Metabolism—APOE—psoriasis	5.1e-05	0.000556	CbGpPWpGaD
Choline—SLC22A2—Metabolism—CYP2S1—psoriasis	5.04e-05	0.00055	CbGpPWpGaD
Choline—ADORA1—Circadian rythm related genes—TP53—psoriasis	5.04e-05	0.00055	CbGpPWpGaD
Choline—PLD1—Immune System—TYK2—psoriasis	5.03e-05	0.000549	CbGpPWpGaD
Choline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	5e-05	0.000546	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—CCL20—psoriasis	4.93e-05	0.000538	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.91e-05	0.000535	CbGpPWpGaD
Choline—PLD2—Metabolism—APOE—psoriasis	4.91e-05	0.000535	CbGpPWpGaD
Choline—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.9e-05	0.000535	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—CCL20—psoriasis	4.87e-05	0.000531	CbGpPWpGaD
Choline—PLD2—Immune System—TYK2—psoriasis	4.84e-05	0.000528	CbGpPWpGaD
Choline—CHAT—Metabolism—APOE—psoriasis	4.74e-05	0.000517	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.72e-05	0.000515	CbGpPWpGaD
Choline—PLD1—Immune System—IFNG—psoriasis	4.71e-05	0.000514	CbGpPWpGaD
Choline—SLC22A1—Metabolism—CYP2S1—psoriasis	4.7e-05	0.000513	CbGpPWpGaD
Choline—ADORA1—Circadian rythm related genes—IL6—psoriasis	4.62e-05	0.000503	CbGpPWpGaD
Choline—ACHE—Metabolism of proteins—ACE—psoriasis	4.61e-05	0.000503	CbGpPWpGaD
Choline—PLD1—Immune System—CD4—psoriasis	4.55e-05	0.000496	CbGpPWpGaD
Choline—PLD2—Immune System—IFNG—psoriasis	4.53e-05	0.000495	CbGpPWpGaD
Choline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.45e-05	0.000486	CbGpPWpGaD
Choline—PLD1—Metabolism—PPARG—psoriasis	4.44e-05	0.000484	CbGpPWpGaD
Choline—ADORA1—GPCR ligand binding—CXCL8—psoriasis	4.39e-05	0.000479	CbGpPWpGaD
Choline—PLD2—Immune System—CD4—psoriasis	4.38e-05	0.000478	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.29e-05	0.000468	CbGpPWpGaD
Choline—ADORA2A—Signaling by NGF—NFKB1—psoriasis	4.28e-05	0.000467	CbGpPWpGaD
Choline—PLD2—Metabolism—PPARG—psoriasis	4.27e-05	0.000466	CbGpPWpGaD
Choline—PLD1—Innate Immune System—IL6—psoriasis	4.22e-05	0.000461	CbGpPWpGaD
Choline—CHAT—Metabolism—PPARG—psoriasis	4.13e-05	0.00045	CbGpPWpGaD
Choline—BCHE—Metabolism of proteins—ACE—psoriasis	4.12e-05	0.000449	CbGpPWpGaD
Choline—PLD1—Immune System—JUN—psoriasis	4.07e-05	0.000444	CbGpPWpGaD
Choline—PLD2—Innate Immune System—IL6—psoriasis	4.07e-05	0.000443	CbGpPWpGaD
Choline—SLC22A3—Metabolism—CARM1—psoriasis	3.93e-05	0.000428	CbGpPWpGaD
Choline—PLD1—Immune System—NFKB1—psoriasis	3.92e-05	0.000427	CbGpPWpGaD
Choline—PLD2—Immune System—JUN—psoriasis	3.92e-05	0.000427	CbGpPWpGaD
Choline—ADORA2A—Circadian rythm related genes—TP53—psoriasis	3.89e-05	0.000425	CbGpPWpGaD
Choline—ADORA2A—Signaling by NGF—STAT3—psoriasis	3.85e-05	0.00042	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—CCL20—psoriasis	3.81e-05	0.000415	CbGpPWpGaD
Choline—PLD2—Immune System—NFKB1—psoriasis	3.77e-05	0.000411	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.68e-05	0.000401	CbGpPWpGaD
Choline—PDE3B—Hemostasis—VEGFA—psoriasis	3.64e-05	0.000397	CbGpPWpGaD
Choline—ADORA2A—Circadian rythm related genes—IL6—psoriasis	3.56e-05	0.000389	CbGpPWpGaD
Choline—PLD1—Immune System—STAT3—psoriasis	3.52e-05	0.000384	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—SOCS1—psoriasis	3.5e-05	0.000382	CbGpPWpGaD
Choline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	3.5e-05	0.000381	CbGpPWpGaD
Choline—PLD2—Immune System—STAT3—psoriasis	3.39e-05	0.00037	CbGpPWpGaD
Choline—ADORA2A—GPCR ligand binding—CXCL8—psoriasis	3.39e-05	0.00037	CbGpPWpGaD
Choline—PDE4C—Signaling by GPCR—TYK2—psoriasis	3.34e-05	0.000364	CbGpPWpGaD
Choline—ACHE—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.32e-05	0.000362	CbGpPWpGaD
Choline—PDE3A—Hemostasis—VEGFA—psoriasis	3.31e-05	0.000361	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.24e-05	0.000353	CbGpPWpGaD
Choline—PDE4C—GPCR downstream signaling—CXCL8—psoriasis	3.2e-05	0.000349	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—SOCS1—psoriasis	3.19e-05	0.000348	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—SOCS1—psoriasis	3.1e-05	0.000338	CbGpPWpGaD
Choline—ACHE—Metabolism—CARM1—psoriasis	3.09e-05	0.000337	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—SOCS1—psoriasis	3.05e-05	0.000332	CbGpPWpGaD
Choline—ADORA2B—Signaling by GPCR—TYK2—psoriasis	3.04e-05	0.000332	CbGpPWpGaD
Choline—BCHE—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.96e-05	0.000323	CbGpPWpGaD
Choline—PDE3B—Signaling by GPCR—TYK2—psoriasis	2.95e-05	0.000322	CbGpPWpGaD
Choline—ADORA2B—GPCR downstream signaling—CXCL8—psoriasis	2.92e-05	0.000318	CbGpPWpGaD
Choline—PDE4C—Signaling by GPCR—CXCL8—psoriasis	2.9e-05	0.000317	CbGpPWpGaD
Choline—PDE4D—Signaling by GPCR—TYK2—psoriasis	2.9e-05	0.000317	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—SOCS1—psoriasis	2.9e-05	0.000316	CbGpPWpGaD
Choline—ACHE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.89e-05	0.000315	CbGpPWpGaD
Choline—ACHE—Metabolism of proteins—LEP—psoriasis	2.87e-05	0.000313	CbGpPWpGaD
Choline—PDE3B—GPCR downstream signaling—CXCL8—psoriasis	2.83e-05	0.000309	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—SOCS1—psoriasis	2.82e-05	0.000308	CbGpPWpGaD
Choline—PDE4D—GPCR downstream signaling—CXCL8—psoriasis	2.78e-05	0.000304	CbGpPWpGaD
Choline—PDE4A—Signaling by GPCR—TYK2—psoriasis	2.76e-05	0.000301	CbGpPWpGaD
Choline—BCHE—Metabolism—CARM1—psoriasis	2.76e-05	0.000301	CbGpPWpGaD
Choline—PDE3B—Hemostasis—TP53—psoriasis	2.75e-05	0.0003	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—SOCS1—psoriasis	2.71e-05	0.000296	CbGpPWpGaD
Choline—PDE3A—Signaling by GPCR—TYK2—psoriasis	2.69e-05	0.000293	CbGpPWpGaD
Choline—ADORA2A—Signaling by NGF—IL6—psoriasis	2.69e-05	0.000293	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—SOCS1—psoriasis	2.68e-05	0.000293	CbGpPWpGaD
Choline—ADORA2B—Signaling by GPCR—CXCL8—psoriasis	2.65e-05	0.000289	CbGpPWpGaD
Choline—PDE4A—GPCR downstream signaling—CXCL8—psoriasis	2.65e-05	0.000289	CbGpPWpGaD
Choline—ADORA1—Signaling by GPCR—TYK2—psoriasis	2.59e-05	0.000282	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—LEP—psoriasis	2.58e-05	0.000282	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—APOE—psoriasis	2.58e-05	0.000282	CbGpPWpGaD
Choline—PDE3A—GPCR downstream signaling—CXCL8—psoriasis	2.58e-05	0.000281	CbGpPWpGaD
Choline—BCHE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.58e-05	0.000281	CbGpPWpGaD
Choline—PDE3B—Signaling by GPCR—CXCL8—psoriasis	2.57e-05	0.00028	CbGpPWpGaD
Choline—PDE4B—Signaling by GPCR—TYK2—psoriasis	2.56e-05	0.000279	CbGpPWpGaD
Choline—BCHE—Metabolism of proteins—LEP—psoriasis	2.56e-05	0.000279	CbGpPWpGaD
Choline—PDE4D—Signaling by GPCR—CXCL8—psoriasis	2.53e-05	0.000276	CbGpPWpGaD
Choline—PDE3A—Hemostasis—TP53—psoriasis	2.5e-05	0.000273	CbGpPWpGaD
Choline—ADORA1—GPCR downstream signaling—CXCL8—psoriasis	2.48e-05	0.000271	CbGpPWpGaD
Choline—SLC22A2—Metabolism—CARM1—psoriasis	2.46e-05	0.000269	CbGpPWpGaD
Choline—PLD1—Immune System—IL6—psoriasis	2.46e-05	0.000268	CbGpPWpGaD
Choline—PDE4B—GPCR downstream signaling—CXCL8—psoriasis	2.45e-05	0.000267	CbGpPWpGaD
Choline—SLC22A3—Metabolism—CAT—psoriasis	2.42e-05	0.000263	CbGpPWpGaD
Choline—PDE4A—Signaling by GPCR—CXCL8—psoriasis	2.41e-05	0.000262	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—NFKBIA—psoriasis	2.41e-05	0.000262	CbGpPWpGaD
Choline—PLD2—Immune System—IL6—psoriasis	2.37e-05	0.000258	CbGpPWpGaD
Choline—PLD2—skin of body—psoriasis	2.36e-05	0.117	CbGeAlD
Choline—ADORA2B—Signaling Pathways—LEP—psoriasis	2.36e-05	0.000257	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—APOE—psoriasis	2.36e-05	0.000257	CbGpPWpGaD
Choline—PDE3A—Signaling by GPCR—CXCL8—psoriasis	2.34e-05	0.000255	CbGpPWpGaD
Choline—SLC22A1—Metabolism—CARM1—psoriasis	2.3e-05	0.00025	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—APOE—psoriasis	2.29e-05	0.000249	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—LEP—psoriasis	2.29e-05	0.000249	CbGpPWpGaD
Choline—ADORA1—Signaling by GPCR—CXCL8—psoriasis	2.25e-05	0.000246	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—LEP—psoriasis	2.25e-05	0.000245	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—APOE—psoriasis	2.25e-05	0.000245	CbGpPWpGaD
Choline—PDE4B—Signaling by GPCR—CXCL8—psoriasis	2.23e-05	0.000243	CbGpPWpGaD
Choline—SLC44A3—tendon—psoriasis	2.22e-05	0.11	CbGeAlD
Choline—ADORA2B—Signaling Pathways—NFKBIA—psoriasis	2.2e-05	0.000239	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—LEP—psoriasis	2.14e-05	0.000233	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—APOE—psoriasis	2.14e-05	0.000233	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—NFKBIA—psoriasis	2.13e-05	0.000232	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—SOCS1—psoriasis	2.1e-05	0.000229	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—NFKBIA—psoriasis	2.09e-05	0.000228	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—APOE—psoriasis	2.08e-05	0.000227	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—LEP—psoriasis	2.08e-05	0.000227	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—APOE—psoriasis	2e-05	0.000218	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—LEP—psoriasis	2e-05	0.000218	CbGpPWpGaD
Choline—CEPT1—tendon—psoriasis	2e-05	0.0992	CbGeAlD
Choline—ADORA2A—Signaling by GPCR—TYK2—psoriasis	2e-05	0.000218	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—NFKBIA—psoriasis	1.99e-05	0.000217	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—APOE—psoriasis	1.98e-05	0.000216	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—LEP—psoriasis	1.98e-05	0.000216	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—TYK2—psoriasis	1.97e-05	0.000215	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—NFKBIA—psoriasis	1.94e-05	0.000211	CbGpPWpGaD
Choline—SLC44A2—tendon—psoriasis	1.93e-05	0.0954	CbGeAlD
Choline—ADORA2A—GPCR downstream signaling—CXCL8—psoriasis	1.92e-05	0.000209	CbGpPWpGaD
Choline—ACHE—Metabolism of proteins—CXCL8—psoriasis	1.9e-05	0.000208	CbGpPWpGaD
Choline—ACHE—Metabolism—CAT—psoriasis	1.9e-05	0.000207	CbGpPWpGaD
Choline—SLC22A3—Metabolism—APOE—psoriasis	1.88e-05	0.000205	CbGpPWpGaD
Choline—CHKA—tendon—psoriasis	1.87e-05	0.0928	CbGeAlD
Choline—ADORA1—Signaling Pathways—NFKBIA—psoriasis	1.87e-05	0.000204	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—NFKBIA—psoriasis	1.84e-05	0.000201	CbGpPWpGaD
Choline—SLC44A1—tendon—psoriasis	1.81e-05	0.0898	CbGeAlD
Choline—ADORA2B—Signaling Pathways—TYK2—psoriasis	1.8e-05	0.000196	CbGpPWpGaD
Choline—PLD2—tendon—psoriasis	1.8e-05	0.0891	CbGeAlD
Choline—PDE3B—Signaling Pathways—TYK2—psoriasis	1.74e-05	0.00019	CbGpPWpGaD
Choline—ADORA2A—Signaling by GPCR—CXCL8—psoriasis	1.74e-05	0.00019	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—CXCL8—psoriasis	1.72e-05	0.000187	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—TYK2—psoriasis	1.72e-05	0.000187	CbGpPWpGaD
Choline—BCHE—Metabolism of proteins—CXCL8—psoriasis	1.7e-05	0.000185	CbGpPWpGaD
Choline—BCHE—Metabolism—CAT—psoriasis	1.7e-05	0.000185	CbGpPWpGaD
Choline—SLC22A3—Metabolism—PPARG—psoriasis	1.63e-05	0.000178	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—TYK2—psoriasis	1.63e-05	0.000178	CbGpPWpGaD
Choline—PDE4C—Signaling by GPCR—IL6—psoriasis	1.63e-05	0.000178	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—JUN—psoriasis	1.6e-05	0.000174	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—TYK2—psoriasis	1.59e-05	0.000173	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—CXCL8—psoriasis	1.57e-05	0.000171	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—LEP—psoriasis	1.55e-05	0.000169	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—APOE—psoriasis	1.55e-05	0.000169	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—NFKB1—psoriasis	1.54e-05	0.000167	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—TYK2—psoriasis	1.53e-05	0.000167	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—CXCL8—psoriasis	1.52e-05	0.000166	CbGpPWpGaD
Choline—SLC22A2—Metabolism—CAT—psoriasis	1.52e-05	0.000165	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—TYK2—psoriasis	1.51e-05	0.000165	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—CXCL8—psoriasis	1.49e-05	0.000163	CbGpPWpGaD
Choline—ADORA2B—Signaling by GPCR—IL6—psoriasis	1.49e-05	0.000162	CbGpPWpGaD
Choline—ACHE—Metabolism—APOE—psoriasis	1.48e-05	0.000161	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—JUN—psoriasis	1.46e-05	0.000159	CbGpPWpGaD
Choline—PDE3B—Signaling by GPCR—IL6—psoriasis	1.44e-05	0.000157	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—NFKBIA—psoriasis	1.44e-05	0.000157	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—CXCL8—psoriasis	1.42e-05	0.000155	CbGpPWpGaD
Choline—PDE4D—Signaling by GPCR—IL6—psoriasis	1.42e-05	0.000155	CbGpPWpGaD
Choline—SLC22A1—Metabolism—CAT—psoriasis	1.41e-05	0.000154	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—JUN—psoriasis	1.41e-05	0.000154	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—NFKB1—psoriasis	1.4e-05	0.000153	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—VEGFA—psoriasis	1.39e-05	0.000152	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—JUN—psoriasis	1.39e-05	0.000151	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—CXCL8—psoriasis	1.38e-05	0.000151	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—STAT3—psoriasis	1.38e-05	0.00015	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—NFKB1—psoriasis	1.36e-05	0.000148	CbGpPWpGaD
Choline—PDE4A—Signaling by GPCR—IL6—psoriasis	1.35e-05	0.000147	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—NFKB1—psoriasis	1.34e-05	0.000146	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—CXCL8—psoriasis	1.33e-05	0.000145	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—JUN—psoriasis	1.32e-05	0.000144	CbGpPWpGaD
Choline—BCHE—Metabolism—APOE—psoriasis	1.32e-05	0.000144	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—CXCL8—psoriasis	1.32e-05	0.000143	CbGpPWpGaD
Choline—PDE3A—Signaling by GPCR—IL6—psoriasis	1.32e-05	0.000143	CbGpPWpGaD
Choline—ACHE—Metabolism—PPARG—psoriasis	1.29e-05	0.00014	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—JUN—psoriasis	1.29e-05	0.00014	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—NFKB1—psoriasis	1.27e-05	0.000139	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—VEGFA—psoriasis	1.27e-05	0.000139	CbGpPWpGaD
Choline—ADORA1—Signaling by GPCR—IL6—psoriasis	1.27e-05	0.000138	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—STAT3—psoriasis	1.26e-05	0.000137	CbGpPWpGaD
Choline—PDE4B—Signaling by GPCR—IL6—psoriasis	1.25e-05	0.000136	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—NFKB1—psoriasis	1.24e-05	0.000135	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—JUN—psoriasis	1.24e-05	0.000135	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—VEGFA—psoriasis	1.23e-05	0.000134	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—JUN—psoriasis	1.22e-05	0.000133	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—STAT3—psoriasis	1.22e-05	0.000133	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—VEGFA—psoriasis	1.21e-05	0.000132	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—STAT3—psoriasis	1.2e-05	0.000131	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—NFKB1—psoriasis	1.19e-05	0.00013	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—TYK2—psoriasis	1.18e-05	0.000129	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—NFKB1—psoriasis	1.18e-05	0.000128	CbGpPWpGaD
Choline—SLC22A2—Metabolism—APOE—psoriasis	1.18e-05	0.000128	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.000126	CbGpPWpGaD
Choline—BCHE—Metabolism—PPARG—psoriasis	1.15e-05	0.000125	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000125	CbGpPWpGaD
Choline—PDE4D—tendon—psoriasis	1.12e-05	0.0557	CbGeAlD
Choline—PDE3A—Signaling Pathways—VEGFA—psoriasis	1.12e-05	0.000122	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—STAT3—psoriasis	1.11e-05	0.000121	CbGpPWpGaD
Choline—SLC22A1—Metabolism—APOE—psoriasis	1.1e-05	0.00012	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—VEGFA—psoriasis	1.08e-05	0.000118	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—STAT3—psoriasis	1.07e-05	0.000117	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—VEGFA—psoriasis	1.07e-05	0.000117	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—STAT3—psoriasis	1.06e-05	0.000115	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—TP53—psoriasis	1.05e-05	0.000115	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—CXCL8—psoriasis	1.03e-05	0.000112	CbGpPWpGaD
Choline—SLC22A2—Metabolism—PPARG—psoriasis	1.03e-05	0.000112	CbGpPWpGaD
Choline—ADORA2A—Signaling by GPCR—IL6—psoriasis	9.77e-06	0.000107	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—IL6—psoriasis	9.64e-06	0.000105	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—TP53—psoriasis	9.61e-06	0.000105	CbGpPWpGaD
Choline—SLC22A1—Metabolism—PPARG—psoriasis	9.56e-06	0.000104	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—JUN—psoriasis	9.56e-06	0.000104	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—TP53—psoriasis	9.32e-06	0.000102	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—NFKB1—psoriasis	9.2e-06	0.0001	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—TP53—psoriasis	9.17e-06	0.0001	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—IL6—psoriasis	8.8e-06	9.59e-05	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—TP53—psoriasis	8.72e-06	9.51e-05	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—IL6—psoriasis	8.53e-06	9.3e-05	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—TP53—psoriasis	8.49e-06	9.26e-05	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—IL6—psoriasis	8.39e-06	9.15e-05	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—VEGFA—psoriasis	8.35e-06	9.1e-05	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—STAT3—psoriasis	8.27e-06	9.01e-05	CbGpPWpGaD
Choline—PDE3A—tendon—psoriasis	8.23e-06	0.0408	CbGeAlD
Choline—ADORA1—Signaling Pathways—TP53—psoriasis	8.17e-06	8.91e-05	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—TP53—psoriasis	8.07e-06	8.8e-05	CbGpPWpGaD
Choline—ADORA1—tendon—psoriasis	8.02e-06	0.0397	CbGeAlD
Choline—PDE4A—Signaling Pathways—IL6—psoriasis	7.99e-06	8.71e-05	CbGpPWpGaD
Choline—ACHE—tendon—psoriasis	7.97e-06	0.0395	CbGeAlD
Choline—PDE3A—Signaling Pathways—IL6—psoriasis	7.77e-06	8.47e-05	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—IL6—psoriasis	7.48e-06	8.16e-05	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—IL6—psoriasis	7.39e-06	8.06e-05	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—TP53—psoriasis	6.31e-06	6.88e-05	CbGpPWpGaD
Choline—SLC22A4—tendon—psoriasis	6.08e-06	0.0301	CbGeAlD
Choline—PDE4B—tendon—psoriasis	5.93e-06	0.0294	CbGeAlD
Choline—ADORA2A—Signaling Pathways—IL6—psoriasis	5.77e-06	6.3e-05	CbGpPWpGaD
Choline—SLC22A5—skin of body—psoriasis	5.28e-06	0.0262	CbGeAlD
Choline—BCHE—skin of body—psoriasis	5.15e-06	0.0255	CbGeAlD
Choline—SLC22A5—tendon—psoriasis	4.02e-06	0.0199	CbGeAlD
